Emerging Role of Fibroblast Growth Factors 15/19 and 21 as Metabolic Integrators in the Liver

被引：98
|
作者：
Cicione, Claudia [1 ]
Degirolamo, Chiara [1 ]
Moschetta, Antonio [1 ,2 ,3 ]
机构：
[1] Consorzio Mario Negri Sud, Dept Translat Pharmacol, Lab Lipid Metab & Canc, Santa Maria Imbaro, CH, Italy
[2] Univ Bari, Clin Med A Murri, Dept Internal & Publ Med, I-66030 Chieti, Italy
[3] Natl Canc Inst Giovanni Paolo II, Bari, Italy
来源：
HEPATOLOGY | 2012年 / 56卷 / 06期
关键词：
ACTIVATED-RECEPTOR-GAMMA; BILE-ACID SYNTHESIS; BETA-KLOTHO; PPAR-ALPHA; HEPATOCELLULAR-CARCINOMA; CIRCADIAN-RHYTHM; TRANSGENIC MICE; MOUSE MODEL; EXPRESSION; FGF21;
D O I：
10.1002/hep.25929
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fibroblast growth factors (FGFs) 15/19 and 21 belong to the FGF endocrine subfamily. They present the intriguing characteristic to be transcribed and secreted in certain tissues and to act as hormones. The insulin-mimetic properties of FGF21 and the regulatory role of FGF15/19 in bile acid and glucose homeostasis endorse these hormones as druggable targets in metabolic disorders. Here, we present details on discoveries, identification, transcriptional regulation, and mechanism of actions of FGF15/19 and FGF21 with a critical perspective view on their putative role as metabolic integrators in the liver. (HEPATOLOGY 2012;56:2404-2411)
引用
收藏
页码：2404 / 2411
页数：8
相关论文
共 50 条
  • [41] Fibroblast Growth Factor 21: A New Liver Safeguard
    Cariello, Marica
    Moschetta, Antonio
    HEPATOLOGY, 2014, 60 (03) : 792 - 794
  • [42] Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
    So, Wing Yan
    Leung, Po Sing
    MEDICINAL RESEARCH REVIEWS, 2016, 36 (04) : 672 - 704
  • [43] Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury
    Christidis, Grigorios
    Karatayli, Ersin
    Hall, Rabea A.
    Weber, Susanne N.
    Reichert, Matthias C.
    Hohl, Mathias
    Qiao, Sen
    Boehm, Ulrich
    Luetjohann, Dieter
    Lammert, Frank
    Karatayli, Senem Ceren
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [44] Emerging Role of the Fibroblast Growth Factor 23/Klotho Axis in Cardiovascular and Metabolic Conditions: A Narrative Review
    Berezin, Alexander E.
    Pavlov, Sergii V.
    Pakholchuk, Olga P.
    JOURNAL OF BIOCHEMICAL TECHNOLOGY, 2020, 11 (02) : 1 - 9
  • [45] Farnesoid X receptor and fibroblast growth factor 15/19 as pharmacological targets
    Maliha, Syeda
    Guo, Grace L.
    LIVER RESEARCH, 2021, 5 (03) : 142 - 150
  • [46] Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
    Jahn, Daniel
    Rau, Monika
    Hermanns, Heike M.
    Geier, Andreas
    CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (06) : 625 - 635
  • [47] Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
    Owen, Bryn M.
    Mangelsdorf, David J.
    Kliewer, Steven A.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (01) : 22 - 29
  • [48] Fibroblast Growth Factor 21 Predicts the Metabolic Syndrome and Type 2 Diabetes in Caucasians
    Bobbert, Thomas
    Schwarz, Franziska
    Fischer-Rosinsky, Antje
    Pfeiffer, Andreas F. H.
    Moehlig, Matthias
    Mai, Knut
    Spranger, Joachim
    DIABETES CARE, 2013, 36 (01) : 145 - 149
  • [49] Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges
    Tian, Haoyu
    Zhang, Shuairan
    Liu, Ying
    Wu, Yifan
    Zhang, Dianbao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [50] Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis
    Li, Shuai
    Jia, Haibo
    Liu, Zhihang
    Wang, Nan
    Guo, Xiaochen
    Cao, Muhua
    Fang, Fang
    Yang, Jiarui
    Li, Junyan
    He, Qi
    Guo, Rui
    Zhang, Teng
    Kang, Kai
    Wang, Zongbao
    Liu, Shijie
    Cao, Yukai
    Jiang, Xinghao
    Ren, Guiping
    Wang, Kai
    Yu, Bo
    Xiao, Wei
    Li, Deshan
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345